According to the Cochran's Q test results (Data S3), heterogeneity was present in overall breast cancer and the luminal A subtype (p < 0.05), whereas the Cochran's Q test results for the HER2‐enriched type showed no significant heterogeneity (p > 0.05). This evidence concerns the gene ERBB2 and breast cancer.